Study finds way to potentially improve immunotherapy for cancer

(Cedars-Sinai Medical Center) A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.

https://www.eurekalert.org/pub_releases/2019-02/cmc-sfw021819.php

Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news